Mumbai Diabetes Care Foundation (MDCF) proudly hosted the launch of Afrezza®, India’s first ultra-rapid inhaled insulin. The event brought together leading diabetes specialists and healthcare professionals to discuss the role of this innovative therapy in advancing diabetes management and improving patient care. This milestone reflects MDCF’s continued commitment to promoting evidence-based innovations, fostering medical education, and enhancing outcomes for people living with diabetes.
20 January 2026